Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) marginally declining and the iShares Biotechnology ETF (IBB) advancing by 0.3%.
IDEXX Laboratories (IDXX) shares were up more than 3% after the company launched the Catalyst proBNP Test, a dual-species in-clinic test for NT-proBNP designed to help veterinarians assess heart disease in cats and dogs.
Legend Biotech (LEGN) stock was up more than 4% after the company reported that it swung to Q2 earnings as revenue increased during the period.
Cardinal Health (CAH) shares were up 0.9% after the company posted higher fiscal Q4 non-GAAP earnings and revenue.